Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b.

× No keyword cloud information.

9 in total

1. Collapsing focal segmental glomerulosclerosis with recovery of renal function: an uncommon complication of interferon therapy for hepatitis C.

Authors: D F Stein; A Ahmed; V Sunkhara; W Khalbuss
Journal: Dig Dis Sci Date: 2001-03 Impact factor: 3.199

Review 2. Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors: R Pisoni; P Ruggenenti; G Remuzzi
Journal: Drug Saf Date: 2001 Impact factor: 5.606

3. Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C.

Authors: Motoyuki Kohjima; Miho Kurokawa; Munechika Enjoji; Tsuyoshi Yoshimoto; Tsukasa Nakamura; Tomoko Ohashi; Kunitaka Fukuizumi; Naohiko Harada; Yusuke Murata; Kazuhisa Matsunaga; Masaki Kato; Kazuhiro Kotoh; Makoto Nakamuta
Journal: Exp Ther Med Date: 2016-03-09 Impact factor: 2.447

Review 4. Interferon alpha sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: case report and review of literature.

Authors: M Colovic; V Jurisic; G Jankovic; D Jovanovic; L J Nikolic; J Dimitrijevic
Journal: J Clin Pathol Date: 2006-08 Impact factor: 3.411

5. Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report.

Authors: Haruomi Nishio; Tatsuo Tsukamoto; Takeshi Matsubara; Yoichiro Okada; Ryosuke Takahashi; Motoko Yanagita
Journal: CEN Case Rep Date: 2016-06-20

6. Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

Authors: Glen S Markowitz; Samih H Nasr; M Barry Stokes; Vivette D D'Agati
Journal: Clin J Am Soc Nephrol Date: 2010-03-04 Impact factor: 8.237

7. A case of deep venous thrombosis associated with pegylated interferon alpha2b plus ribavirin treatment of chronic hepatitis C.

Authors: Chiaki Okuse; Kayo Adachi; Yoshiki Katakura; Kotaro Matsunaga; Toshiya Ishii; Nobuyuki Matsumoto; Hiroshi Yotsuyanagi; Shiro Iino; Michihiro Suzuki; Fumio Itoh
Journal: J Gastroenterol Date: 2007-02-06 Impact factor: 7.527

8. Thrombotic microangiopathy associated with use of interferon-beta.

Authors: Teresa Olea; Raquel Díaz-Mancebo; Maria-Luz Picazo; Jorge Martínez-Ara; Angel Robles; Rafael Selgas
Journal: Int J Nephrol Renovasc Dis Date: 2012-06-15

Review 9. Anti-hepatitis C virus drugs and kidney.

Authors: Paul Carrier; Marie Essig; Marilyne Debette-Gratien; Denis Sautereau; Annick Rousseau; Pierre Marquet; Jérémie Jacques; Véronique Loustaud-Ratti
Journal: World J Hepatol Date: 2016-11-18

9 in total